$5.99
Price
$2.2B
Market Cap
6.2
P/E Ratio
1.4
Forward P/E
$0.97
EPS (TTM)
—
Dividend Yield
$1.3B
Cash
$21.6B
Total Debt
371M
Shares Out
$4.25
$8.69
52-Week Range
Institutional Ownership of BAUSCH HEALTH COS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Third Point LLC|Daniel Loeb
|
350.0K | $2M | $6.81 | +6.61% |
Trading Activity for BAUSCH HEALTH COS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q4 | |||||
| BUY | +250.0% | 350.0K | $2M | $6.62 | |
| 2025-Q3 | |||||
| SELL | EXIT | — | — | $6.81 | |
| BUY | NEW | 100.0K | $645000 | $6.81 | |
| 2024-Q2 | |||||
| SELL | EXIT | — | — | $7.03 | |
| 2023-Q3 | |||||
| SELL | EXIT | — | — | $8.43 | |
| 2023-Q2 | |||||
| SELL | -60.0% | 1.0M | $8M | $7.42 | |
| 2022-Q4 | |||||
| SELL | EXIT | — | — | $6.92 | |
| SELL | EXIT | — | — | $6.92 | |
| 2022-Q3 | |||||
| SELL | EXIT | — | — | $7.04 | |
| SELL | -39.2% | 1.6M | $11M | $7.04 | |
| SELL | -53.7% | 187.6K | $1M | $7.04 | |
| 2022-Q2 | |||||
| SELL | -0.6% | 14.3M | $120M | $10.15 | |
| SELL | -16.2% | 2.6M | $21M | $10.15 | |
| SELL | -6.5% | 715.0K | $6M | $10.15 | |
| BUY | +49.5% | 405.5K | $3M | $10.15 | |
| 2022-Q1 | |||||
| SELL | -7.6% | 14.4M | $330M | $24.32 | |
| SELL | -0.3% | 3.1M | $70M | $24.32 | |
| SELL | -6.5% | 271.3K | $6M | $24.32 | |
| 2021-Q4 | |||||
| BUY | +1.8% | 34.7M | $959M | $27.25 | |
| SELL | -13.0% | 15.6M | $431M | $27.25 | |
| BUY | +1.6% | 3.1M | $85M | $27.25 | |
| SELL | -48.8% | 765.0K | $21M | $27.25 | |
| 2021-Q3 | |||||
| SELL | -9.4% | 3.0M | $84M | $28.59 | |
| BUY | +263.2% | 2.5M | $70M | $28.59 | |
| 2021-Q2 | |||||
| BUY | +2.5% | 3.3M | $98M | $30.28 | |
| BUY | NEW | 688.3K | $20M | $30.28 | |
| 2021-Q1 | |||||
| BUY | +577.7% | 34.1M | $1.1B | $30.86 | |
| SELL | -5.4% | 3.3M | $103M | $30.86 | |
| SELL | -2.9% | 1.5M | $47M | $30.86 | |
| 2020-Q4 | |||||
| BUY | +0.1% | 17.9M | $373M | $19.16 | |
| BUY | NEW | 5.0M | $105M | $19.16 | |
| BUY | +0.7% | 3.4M | $72M | $19.16 | |
| 2020-Q3 | |||||
| BUY | +8.0% | 3.4M | $53M | $17.19 | |
| 2020-Q2 | |||||
| BUY | +10.4% | 3.2M | $58M | $17.85 | |
| SELL | -1.3% | 1.5M | $27M | $17.85 | |
| 2020-Q1 | |||||
| SELL | -26.6% | 2.9M | $44M | $27.43 | |
| SELL | -5.5% | 1.6M | $24M | $27.43 | |
| 2019-Q4 | |||||
| SELL | -13.7% | 3.9M | $117M | $27.38 | |
| 2019-Q3 | |||||
| SELL | -2.9% | 4.5M | $99M | $22.91 | |
| 2019-Q2 | |||||
| SELL | -0.6% | 17.9M | $452M | $23.80 | |
| SELL | -2.6% | 4.6M | $117M | $23.80 | |
| 2019-Q1 | |||||
| SELL | -0.6% | 4.8M | $118M | $24.03 | |
| 2018-Q4 | |||||
| SELL | -2.5% | 4.8M | $89M | $24.20 | |
| 2018-Q3 | |||||
| BUY | NEW | 18.0M | $463M | $22.93 | |
| BUY | NEW | 4.9M | $126M | $22.93 | |
| BUY | NEW | 1.6M | $42M | $22.93 | |
Insider Trading for BAUSCH HEALTH COS INC
6 Months Insider Sentiment
Buy $15.6M
Sell $98K
1
Buys
1
Sells
+15.5M
Net
6
Grants
Largest
$15.6M
INC.
$98K
Carson
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | Amy B Wechsler | Director | GRANT | 989 | — | — |
| Dec 31, 2025 | Sandra Leung | Director | GRANT | 4.6K | — | — |
| Dec 31, 2025 | John Paulson | Director | GRANT | 9.0K | — | — |
| Nov 25, 2025 | PAULSON & CO. INC. | 10% Owner | BUY | 2.50M | $6.25 | $15.6M |
| Sep 30, 2025 | Amy B Wechsler | Director | GRANT | 1.1K | — | — |
| Sep 30, 2025 | John Paulson | Director | GRANT | 9.7K | — | — |
| Sep 30, 2025 | Sandra Leung | Director | GRANT | 3.7K | — | — |
| Sep 08, 2025 | Seana Carson | EVP, General Counsel | SELL | 13.4K | $7.31 | $98K |